Should We Taper or not: A Short Glance to a Dilemma
PDF
Cite
Share
Request
Editorial Note
VOLUME: 29 ISSUE: 2
P: 0 - 0
April 2018

Should We Taper or not: A Short Glance to a Dilemma

Gazi Med J 2018;29(2):0-0
1. Gazi University Faculty of Medicine, Department of Pediatric Cardiology, Ankara, Turkey
2. Gazi University Faculty of Medicine, Ankara, Turkey
No information available.
No information available
Received Date: 10.16.2017
Accepted Date: 10.20.2017
PDF
Cite
Share
Request

The treatment of the acute inflammatory manifestations of acute rheumatic fever (ARF) refers to the utilization of anti-inflammatory agents. Based upon clinical experience, acetylsalicylic acid (ASA) has been traditionally accepted as the first-line therapy for arthritis. However, various scientific sources indicate different schedules for the administration of ASA treatment and such differences may cause misunderstandings.

This student study aims to investigate the approaches for the ASA treatment that have been adopted by the pediatric cardiologists in the treatment of ARF arthritis by means of a pre-designed questionnaire.

Keywords:
Acetyl salicylic acid, acute rheumatic fever